...
首页> 外文期刊>Journal of Thoracic Disease >Different characteristics associated with intensive care unit transfer from the medical ward between patients with acute exacerbations of chronic obstructive pulmonary disease with and without pneumonia
【24h】

Different characteristics associated with intensive care unit transfer from the medical ward between patients with acute exacerbations of chronic obstructive pulmonary disease with and without pneumonia

机译:在患有和不患有肺炎的慢性阻塞性肺疾病急性加重患者之间,从重症监护病房从病房转移的不同特征

获取原文

摘要

Background: The rate of hospitalization due to acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is increasing. Few studies have examined the clinical, laboratory and treatment differences between patients in general wards and those who need transfer to an intensive care unit (ICU). Methods: We retrospectively reviewed clinical, laboratory, and treatment characteristics of 374 patients who were initially admitted to the general ward at Chonnam National University Hospital in South Korea due to AECOPD (pneumonic, 194; non-pneumonic, 180) between January 2008 and March 2015. Of these patients, 325 were managed at the medical ward during their hospitalization period (ward group), and 49 required ICU transfer (ICU group). We compared the clinical, laboratory, and treatment characteristics associated with ICU transfer between patients with AECOPD with and without pneumonia. Results: Male patients were 86.5% in the ward group and 79.6% in the ICU group. High glucose levels [median 154.5 mg/dL, interquartile range (IQR) 126.8–218.3 in ICU group vs. median 133.0, IQR 109.8–160.3 in ward group], high pneumonia severity index scores (median 100.5, IQR 85.5–118.5 vs. median 86.0, IQR 75.0–103.5), low albumin levels (median 2.9 g/dL, IQR 2.6–3.6 vs . median 3.4, IQR 3.0–3.7), and anemia (73.3% vs . 43.3%) independently increased the risk of ICU transfer in the pneumonic AECOPD group. High PaCO 2 levels (median 53.1 mmHg in ICU group, IQR 38.5–84.6 vs . median 39.7, IQR 34.2–48.6 in ward group) independently increased the risk of ICU transfer in the non-pneumonic AECOPD group. Treatment with systemic corticosteroids (≥30 mg of daily prednisolone) during hospitalization in the medical ward independently reduced the risk of ICU transfer in both groups. Conclusions: The characteristics associated with ICU transfer differed between the pneumonic and non-pneumonic AECOPD groups, and systemic corticosteroids use was associated with lower rate of ICU transfer in both groups.
机译:背景:慢性阻塞性肺疾病(AECOPD)急性加重导致的住院率正在上升。很少有研究检查普通病房患者和需要转入重症监护病房(ICU)的患者之间在临床,实验室和治疗方面的差异。方法:我们回顾性分析了2008年1月至3月之间因AECOPD(194例肺炎,180例非肺炎)入院于韩国忠南国立大学医院普通病房的374例患者的临床,实验室和治疗特点。 2015年。在这些患者中,有325名在住院期间在医疗病房接受了治疗(病房组),其中49名需要ICU转移(ICU组)。我们比较了有和没有肺炎的AECOPD患者之间与ICU转移相关的临床,实验室和治疗特征。结果:病房组男性患者为86.5%,ICU组为79.6%。高血糖水平[ICU组中位数154.5 mg / dL,四分位间距(IQR)126.8–218.3,病区组中位数133.0,IQR 109.8–160.3],肺炎严重程度指数得分高(中位数100.5,IQR 85.5-118.5vs。中位数86.0,IQR 75.0-103.5),低白蛋白水平(中位数2.9 g / dL,IQR 2.6-3.6与中位数​​3.4,IQR 3.0-3.7)和贫血(73.3%对43.3%)独立地增加了ICU的风险在肺AECOPD组中转移。 PaCO 2的高水平(ICU组中位值为53.1 mmHg,病房组中位值为39.7,IQR为39.7-84.6,病房组中位值为39.7,IQR 34.2-48.6)独立增加了非肺炎性AECOPD组ICU转移的风险。在病房住院期间用全身性皮质类固醇激素(每日泼尼松龙≥30 mg)治疗可独立降低两组ICU转移的风险。结论:肺炎和非肺炎AECOPD组与ICU转移相关的特征有所不同,并且全身性皮质类固醇的使用与两组ICU转移率较低相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号